Format

Send to

Choose Destination
Brain Res Bull. 2002 Apr;57(6):795-808.

Stem cells in the treatment of Parkinson's disease.

Author information

1
Laboratory of Molecular Neurobiology, Karolinska Institute, Stockholm, Sweden. ernest.arenas@mbb.ki.se

Abstract

Stem cells have been suggested as candidate therapeutic tools for neurodegenerative disorders, given their ability to give rise to the appropriate cell types after grafting in vivo. In this review I summarize some of the evidence currently available concerning two approaches for the treatment of Parkinson's disease: (1) The generation of dopaminergic neurons from embryonic stem cells, multipotent stem cells, and neuronal progenitor cells for cell replacement therapy. (2) The engineering of multipotent stem cells to release glial cell-line derived neurotrophic factor, a potent neurotrophic factor for dopaminergic neurons, in a neuroprotective and neuroregenerative approach to the treatment of Parkinson's disease.

PMID:
12031276
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center